{
  "id": 14433224,
  "title": "Verastem Oncology Names Michael Bailey CEO",
  "url": "https://urgent.news/2026/10/14/verastem-oncology-names-michael-bailey-ceo",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-14T10:23:33.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/verastem-oncology-names-michael-bailey-ceo"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Verastem, Inc. (VSTM), a biopharmaceutical company focused on developing and commercializing medicines for cancer treatment, said Wednesday that it has appointed Michael P. Bailey as President and Chief Executive Officer, effective January 1, 2027.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Verastem names Michael Bailey as CEO effective January 2027",
        "url": "https://urgent.news/2026/10/14/verastem-names-michael-bailey-as-ceo-effective-january-2027",
        "published": "2026-10-14T10:08:36.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}